Literature DB >> 20691755

The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6/J mice.

Sang Su Oh1, John M Hayes, Catrina Sims-Robinson, Kelli A Sullivan, Eva L Feldman.   

Abstract

Animal models, particularly mice, are used extensively to investigate neurological diseases. Basic research regarding animal models of human neurological disease requires that the animals exhibit hall mark characteristics of the disease. These include disease specific anatomical, metabolic and behavioral changes. Nerve conduction velocity (NCV) is the predominant method used to assess peripheral nerve health. Normative data adjusted for age, gender and height is available for human patients; however, these data are not available for most rodents including mice. NCV may be affected by animal age and size, body temperature, stimulus strength and anesthesia. While the effects of temperature, age and size are documented, the direct and indirect effects of anesthesia on NCV are not well reported. Our laboratory is primarily concerned with animal models of diabetic neuropathy (DN) and uses NCV to confirm the presence of neuropathy. To ensure that subtle changes in NCV are reliably assayed and not directly or indirectly affected by anesthesia, we compared the effects of 4 commonly used anesthetics, isoflurane, ketamine/xylazine, sodium pentobarbital and 2-2-2 tribromoethanol on NCV in a commonly used rodent model, the C57Bl6/J mouse. Our results indicate that of the anesthetics tested, isoflurane has minimal impact on NCV and is the safest, most effective method of anesthesia. Our data strongly suggest that isoflurane should become the anesthetic of choice when performing NCV on murine models of neurological disease. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691755      PMCID: PMC2941214          DOI: 10.1016/j.neulet.2010.07.076

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  37 in total

Review 1.  Diagnosis, natural history, and management of Charcot-Marie-Tooth disease.

Authors:  Davide Pareyson; Chiara Marchesi
Journal:  Lancet Neurol       Date:  2009-07       Impact factor: 44.182

Review 2.  Toxic neuropathies associated with pharmaceutic and industrial agents.

Authors:  Zachary London; James W Albers
Journal:  Neurol Clin       Date:  2007-02       Impact factor: 3.806

3.  Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice.

Authors:  Timothy D Wiggin; Matthias Kretzler; Subramaniam Pennathur; Kelli A Sullivan; Frank C Brosius; Eva L Feldman
Journal:  Endocrinology       Date:  2008-06-26       Impact factor: 4.736

4.  Mouse models of diabetic neuropathy.

Authors:  Kelli A Sullivan; John M Hayes; Timothy D Wiggin; Carey Backus; Sang Su Oh; Stephen I Lentz; Frank Brosius; Eva L Feldman
Journal:  Neurobiol Dis       Date:  2007-07-31       Impact factor: 5.996

5.  Safety and efficacy of various combinations of injectable anesthetics in BALB/c mice.

Authors:  Sandra Buitrago; Thomas E Martin; Joanne Tetens-Woodring; Alan Belicha-Villanueva; Gregory E Wilding
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-01       Impact factor: 1.232

Review 6.  Diabetic neuropathy: mechanisms to management.

Authors:  James L Edwards; Andrea M Vincent; Hsinlin T Cheng; Eva L Feldman
Journal:  Pharmacol Ther       Date:  2008-06-13       Impact factor: 12.310

Review 7.  Chronic neuropathies - chronic inflammatory demyelinating neuropathy and its variants.

Authors:  Sindhu Ramchandren; Richard A Lewis
Journal:  Front Neurol Neurosci       Date:  2009-04-06

Review 8.  Criteria for creating and assessing mouse models of diabetic neuropathy.

Authors:  Kelli A Sullivan; Stephen I Lentz; John L Roberts; Eva L Feldman
Journal:  Curr Drug Targets       Date:  2008-01       Impact factor: 3.465

Review 9.  Management of chronic pain in cancer survivors.

Authors:  Michael H Levy; Marcin Chwistek; Rohtesh S Mehta
Journal:  Cancer J       Date:  2008 Nov-Dec       Impact factor: 3.360

10.  Comparison of cardiovascular effects of tiletamine-zolazepam, pentobarbital, and ketamine-xylazine in male rats.

Authors:  Dhanonjoy C Saha; Animita C Saha; Gautam Malik; Mark E Astiz; Eric C Rackow
Journal:  J Am Assoc Lab Anim Sci       Date:  2007-03       Impact factor: 1.232

View more
  30 in total

1.  Early and Late Loss of the Cytoskeletal Scaffolding Protein, Ankyrin G Reveals Its Role in Maturation and Maintenance of Nodes of Ranvier in Myelinated Axons.

Authors:  Julia Saifetiarova; Anna M Taylor; Manzoor A Bhat
Journal:  J Neurosci       Date:  2017-02-01       Impact factor: 6.167

2.  Stimulus-dependent changes in optical responses of the dorsal cochlear nucleus using voltage-sensitive dye.

Authors:  F G Licari; M Shkoukani; J A Kaltenbach
Journal:  J Neurophysiol       Date:  2011-05-04       Impact factor: 2.714

Review 3.  The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease.

Authors:  Bhumsoo Kim; Sarah E Elzinga; Rosemary E Henn; Lisa M McGinley; Eva L Feldman
Journal:  Neurobiol Dis       Date:  2019-07-23       Impact factor: 5.996

4.  The Divergent Roles of Dietary Saturated and Monounsaturated Fatty Acids on Nerve Function in Murine Models of Obesity.

Authors:  Amy E Rumora; Giovanni LoGrasso; John M Hayes; Faye E Mendelson; Maegan A Tabbey; Julia A Haidar; Stephen I Lentz; Eva L Feldman
Journal:  J Neurosci       Date:  2019-03-18       Impact factor: 6.167

5.  Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy.

Authors:  Lucy M Hinder; Andrea M Vincent; John M Hayes; Lisa L McLean; Eva L Feldman
Journal:  Exp Neurol       Date:  2012-10-08       Impact factor: 5.330

6.  Morphing electronics enable neuromodulation in growing tissue.

Authors:  Yuxin Liu; Jinxing Li; Shang Song; Jiheong Kang; Yuchi Tsao; Shucheng Chen; Vittorio Mottini; Kelly McConnell; Wenhui Xu; Yu-Qing Zheng; Jeffrey B-H Tok; Paul M George; Zhenan Bao
Journal:  Nat Biotechnol       Date:  2020-04-20       Impact factor: 54.908

7.  Axonal domain disorganization in Caspr1 and Caspr2 mutant myelinated axons affects neuromuscular junction integrity, leading to muscle atrophy.

Authors:  Julia Saifetiarova; Xi Liu; Anna M Taylor; Jie Li; Manzoor A Bhat
Journal:  J Neurosci Res       Date:  2017-04-03       Impact factor: 4.164

8.  Use of Nerve Conduction Velocity to Assess Peripheral Nerve Health in Aging Mice.

Authors:  Michael E Walsh; Lauren B Sloane; Kathleen E Fischer; Steven N Austad; Arlan Richardson; Holly Van Remmen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-12-03       Impact factor: 6.053

9.  Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story.

Authors:  Lucy M Hinder; Benjamin J Murdock; Meeyoung Park; Diane E Bender; Phillipe D O'Brien; Amy E Rumora; Junguk Hur; Eva L Feldman
Journal:  Exp Neurol       Date:  2018-03-14       Impact factor: 5.330

10.  In vivo electrophysiological measurements on mouse sciatic nerves.

Authors:  Alexander Schulz; Christian Walther; Helen Morrison; Reinhard Bauer
Journal:  J Vis Exp       Date:  2014-04-13       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.